CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014

  CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4,
                                     2014

PR Newswire

SEATTLE, July 28, 2014

SEATTLE, July 28, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI) (NASDAQ and
MTA: CTIC) announced today that it will report its second quarter 2014
financial results on Monday, August 4, 2014, after the close of the U.S.
financial markets. Following the announcement, members of the management team
will host a webcast conference call to discuss the results and provide a
general corporate update at 4:30 p.m. EDT (1:30 p.m. PDT). Access to the event
can be obtained as follows:

Monday, August 4
1:30 p.m. PDT/4:30 p.m. EDT/10:30 p.m. CEST
1-888-461- 2024 (domestic)
+1 719-325-2464 (international)

To access the live audio webcast or the subsequent archived recording, visit
CTI's website, www.ctibiopharma.com. Webcast and telephone replays of the
conference call will be available at approximately two hours after completion
of the call. Callers can access the replay by dialing 1-888-203-1112
(domestic) or +1 719-457-0820 (international). The access code for the replay
is #1937280. The telephone replay will be available untilMonday, August 11,
2014.

About CTI BioPharma

CTI BioPharma Corp. (NASDAQ and MTA: CTIC) is a biopharmaceutical company
focused on the acquisition, development and commercialization of novel
targeted therapies covering a spectrum of blood-related cancers that offer a
unique benefit to patients and healthcare providers. CTI has a commercial
presence in Europe and a late-stage development pipeline, including
pacritinib, CTI's lead product candidate that is currently being studied in a
Phase 3 program for the treatment of patients with myelofibrosis. CTI is
headquartered in Seattle, Washington, with offices in London and Milan under
the name CTI Life Sciences Limited. For additional information and to sign up
for email alerts and get RSS feeds, please visit www.ctibiopharma.com.

Contacts:
Monique Greer
+1 206-272-4343
mgreer@ctibiopharma.com 

Ed Bell
+1 206-282-7100
ebell@ctibiopharma.com 

In Europe: CTI Life Sciences Limited, Milan Branch
Laura Villa
+39 02 94751572
lvilla@cti-lifesciences.com

SOURCE CTI BioPharma Corp.

Website: http://www.ctibiopharma.com
 
Press spacebar to pause and continue. Press esc to stop.